# Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations

> **NCT05140499** · PHASE4 · TERMINATED · sponsor: **Aurora Quaye** · enrollment: 11 (actual)

## Conditions studied

- Pain, Postoperative
- Amputation

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine Hydrochloride 0.5 % Injectable Solution

## Key facts

- **NCT ID:** NCT05140499
- **Lead sponsor:** Aurora Quaye
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-15
- **Primary completion:** 2025-11-20
- **Final completion:** 2025-12-23
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Difficulty with enrollment
- **Last updated:** 2026-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05140499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05140499, "Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05140499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*